{
  "type": "ref",
  "text": "These data indicate that thrombin activates endothelial ICAM-1 expression and polymorphonuclear leukocyte adhesion by NF-kappa Bp65 binding to the downstream NF-kappa B site of ICAM-1 promoter after proteolytically activated receptor-1 activation.\n",
  "self": {
    "NER": {
      "answers": [],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": []
      }
    },
    "NOUN": {
      "answers": [
        "These data",
        "thrombin",
        "endothelial ICAM-1 expression and polymorphonuclear leukocyte adhesion",
        "NF-kappa",
        "the downstream NF-kappa B site",
        "ICAM-1 promoter",
        "proteolytically activated receptor-1 activation"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What indicates that thrombin activates endothelial ICAM-1 expression?",
          "What is the name of the drug that activates endothelial ICAM-1 expression",
          "What does thrombin activate?",
          "What binding site does thrombin activate?",
          "Where does thrombin binding to ICAM-1 promoter?",
          "What is the downstream site of NF-kappa B?",
          "What is the process that thrombin activates?"
        ]
      }
    }
  },
  "asked": {
    "What was inhibited when either the Elf-1 or HMG-I(Y)": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.017594873905181885,
        "ground_truth": {
          "Stimulation": {
            "bertscore": 0.672673761844635,
            "f1": 0
          }
        }
      }
    },
    "What did NF-kappaB p65 binding to inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.017937064170837402,
        "ground_truth": {
          "the ICAM-1 promoter": {
            "bertscore": 0.6218081116676331,
            "f1": 0
          }
        }
      }
    }
  }
}